Skip to Content
The Big Picture San Diego Blog


BD

August 23, 2018

Last week, EDC welcomed a group of next-gen life sciences leaders to San Diego for an exclusive tour of the region’s life sciences industry. Over two days, 26 eager PhD candidates representing 15 schools across 11 states paid visits to seven local employers including ResMed, Takeda, BD, Janssen/JLABS, Thermo Fisher Scientific, Dexcom, and Rady Children’s Institute for Genomic Medicine. Upon completion of their PhD program, these students will enter high-demand occupations within the life sciences industry – namely, positions in bioinformatics, computational biology, genomics, and more. Our hope is that they chose to do so in our region.

EDC launched the San Diego Life Sciences Trek in 2017 as a strategy for attracting talent to support the growth of the region’s life sciences industry, mirroring the more typical MBA Trek model. Across the globe, leaders in genomics and connected health are gathering incomprehensible amounts of data with the power to unlock the human genome, make personalized care a reality, and enhance the way we live on a massive scale. Individuals skilled in bioinformatics, data science, and computational biology are instrumental in deciphering such data sets – a task with stunning implications across pharma, biotech, healthcare, genomics, and much more – and are thus highly sought after by companies and regions alike. The battle for talent is heating up.

Many trek participants attend this two-day program because they are curious about a career in industry, but with backgrounds in academia, have had limited opportunities to explore what one might look like. The Life Sciences Trek provides students a chance to get out from behind the lab bench to tour companies, talk with real professionals, and learn how their skills can be applied in life-changing companies in San Diego.

Through company tours, panel discussions, presentations, and a networking reception, students gained access to influential researchers and executives across leading life sciences employers. From drug discovery to connected devices, genetic sequencing to direct patient care, the breadth of opportunities for bioinformaticians became apparent within San Diego’s diverse life sciences ecosystem. In fact, after attending the trek, 90 percent of participants indicated that they plan to pursue a career in San Diego upon completion of their PhD program.

Below are their thoughts. See more at #SDlifesciencestrek.

“It was a fantastic experience for someone who's always been immersed in academia, but is interested in the industry.”

– PhD candidate in Bioinformatics, University of Michigan

“This was an incredible opportunity to network with the scientists that could be involved in hiring you in the future. It was an indispensable experience to see first hand the types of jobs that recent PhD graduates could be qualified for.”

– PhD candidate in Neuroscience, University of Southern California

“Seeing the positive testimonials from all the people at the companies regardless of their position about work-life culture will make me prioritize San Diego as my primary target for future job applications.”

 – PhD candidate in Animal Biology with a focus on Biotechnology, UC Davis

“The trek was really eye-opening and definitely changed my perspective about potentially pursuing a career there!”

– PhD candidate in Cell and Molecular Biology, University of Southern California

“The SD trek is a great opportunity to familiarize yourself with biotech opportunities in SD and to learn about a great town with a lot of potential for aspiring scientists.”

– PhD candidate in Microbiology and Immunology, Dartmouth College

 

The trek group represented 15 schools: Carnegie Melon, Cornell, Dartmouth, Duke, Georgia Tech, Stanford, Ohio State, UC Davis, UC San Diego, UC Santa Cruz, University of Southern California, University of Idaho, University of Illinois, University of Michigan, University of Texas. 


Trek highlights: Surprise guest Dr. Stephen Kingsmore, CEO of Rady Children’s Institute for Genomic Medicine and Guinness World Record holder for fastest genetic diagnosis through DNA sequencing.

  

You can't talk about San Diego life sciences without talking about startups. Trek participants tour JLABS followed by a panel discussion moderated by Ashley Van Zeeland, co-founder of Cypher Genomics and former CTO of Human Longevity.

 

 

February 1, 2016
 
 
As a major win for the region’s innovation economy, today, Mayor Kevin L. Faulconer and San Diego Regional EDC announced that BD (Becton, Dickinson and Company), the world’s largest medication management company, will be maintaining its presence in San Diego, keeping more than 3,000 jobs in the region.
 
Mayor Kevin L. Faulconer said, “San Diego is now home to the single largest medication management company in the world.   I’m proud BD has committed to building upon CareFusion’s legacy in San Diego, which means that more than 3,000 locals can continue to rely on this company to help them take care of their families, put food on the table and a roof over their heads.”  
 
Bill Kozy, Executive Vice President and Chief Operating Officer of BD said, “San Diego is home to more BD associates than any other city in the world. The region not only offers a great place for associates to live, but it is also home to world-class health care facilities, great universities and many innovative companies that create a highly educated talent pool and opportunities for unique collaborations.”
 
Mark Cafferty, President & CEO, San Diego Regional EDC said, “BD and its 3,000 employees are staying and growing in San Diego. As a company, BD is an example of what happens when leaders collaborate and a global company continues to invest in our regional economy.”

Congressman Scott Peters said, “BD’s decision to invest their future in San Diego demonstrates the strength of our world-class innovation economy and organizations like the San Diego EDC that support it. This move also means thousands of high-quality jobs for {C}San Diego’s increasingly talented workforce. We must continue to drive economic growth and create the jobs of the future in San Diego by permanently eliminating barriers to success for our innovators and entrepreneurs like the harmful medical device tax.”
 
Panorea Avdis, Director of Governor's Office of Business and Economic Development (GO-Biz) said, “GO-Biz applauds our local partners, Mayor Faulconer’s office and San Diego Regional EDC for their work to keep BD in San Diego and we look forward to continuing to work with the company as they expand in California."
 
In 2015, BD merged with San Diego-based CareFusion, creating a $12 billion company—one of the largest medical technology companies in the world. BD has embraced San Diego and will be growing its footprint locally. As a globally-oriented company, BD has a presence in more than 80 countries, yet it currently has more employees in San Diego than any other city in the world.
 
Tapping into San Diego’s strong medical device and engineering talent, BD will be creating a new global center for health informatics on its Torrey View campus. In addition, the company will also be maintain its manufacturing capabilities in the San Diego region.
 
Since BD announced its acquisition of CareFusion in early 2015, the City of San Diego and San Diego Regional EDC have been working with BD to ensure the newly-integrated company continues to build off the strong legacy San Diego CareFusion has created.